Pharmafile Logo
Pharmafocus logo
Advanced Search

Japan

Showing 15 posts of 81 posts found.

landing-hero-images1

Japan welcomes approval of ViiV’s Dovato for HIV-1

January 17, 2020
Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …

News
mask-1954673_1280

China’s viral pneumonia spreads to Japan

January 17, 2020
Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …

News
japan-112722_640

Lundbeck and Takeda’s depression drug approved in Japan

September 20, 2019
Medical Communications, Sales and Marketing Japan, Lundbeck, Takeda, major depressive disorder, pharma

Takeda and Lundbeck have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has chosen to authorise their drug …

News

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019
Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

News
takeda_global_hq

Takeda scores Japanese Entyvio approval in Crohn’s disease

May 22, 2019
Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Japan, crohn's disease, pharma

Takeda has announced that Japan’s drug regulator, the Ministry of Health, Labour and Welfare (MHLW), has approved Entyvio (vedolizumab) in …

News
novartis_window

Novartis’ Kymriah to be covered by Japan’s national insurance system

May 16, 2019
Medical Communications, Sales and Marketing CAR T, CAR-T, Japan, Kymriah, Novartis, pharma

Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical …

News

US prescription drugs most expensive in world, analysis shows

May 8, 2019
Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …

News

Takeda opens R&D facility in San Diego, California

May 2, 2019
Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …

News

Japanese court orders public health campaigner to pay ¥3.3 million to anti-vaccine researcher

March 27, 2019
Medical Communications, Research and Development HPV, Japan, anti vaxx, anti-vaccine, public health, vaccines

Dr Riko Muranaka, a researcher and journalist who has campaigned against misinformation surrounding vaccines, has been ordered to pay ¥3.3 …

News
abbvie_0

Japan awards AbbVie’s Skyrizi with first approval, in 4 psoriasis indications

March 27, 2019
Research and Development, Sales and Marketing AbbVie, Japan, Skyrizi, pharma, psoriasis

AbbVie has announced that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has been awarded approval in Japan from the nation’s Ministry …

News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …

Appointment

Japanese researchers to trial stem cell therapy in four patients with serious spinal injuries

February 19, 2019
Manufacturing and Production Japan, Keio University, Parkinson's, cell therapy, iPS

The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …

News
8mfhvyr9ncnz2pmccioqrzf1kgnqnvsr

UK-Japan partnership to see collaboration on incurable diseases, green technology and AI

January 11, 2019
Medical Communications AI, Japan, MRC, UK, international partnership, medicine, technology

A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …

News
bonecells

Amgen and UCB’s Evenity approved in Japan for osteoporosis

January 9, 2019
Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …

News
bmssyracuseny

Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn

December 19, 2018
Business Services BMS, Japan, M&A, MA, Taisho, deal

Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business. With more than a …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024